Explore 3 Stock Ideas & Industry Insights Download Free Report
GENinCode PLC (LSE:GENI) trades on the London Stock Exchange’s AIM market, where corporate developments and expectations about future cash flows can strongly influence sentiment. The most relevant identified company context is cardiovascular genetic risk testing commercialisation. This information provides a grounded starting point for …
OptiBiotix Health PLC (LSE:OPTI) trades on the London Stock Exchange’s AIM market, where corporate developments and expectations about future cash flows can strongly influence sentiment. The most relevant identified company context is 17 September interim results showing revenue of GBP 679,000, up 21.9%, and …
RUA Life Sciences Plc (LSE:RUA) is assessed against its operating exposure to medical device and biomaterials technologies. The relevant investor questions concern commercial adoption and regulatory progress.
Shield Therapeutics is a commercial-stage pharmaceutical company focused on iron deficiency. Its sole marketed product, ferric maltol, is an oral iron therapy sold as ACCRUFeR in the United States and as Feraccru in Europe and other markets. The company sells directly in the US …
ValiRx describes itself as a life science company focused on early-stage cancer therapeutics and women's health. Its model is to source promising academic or early commercial assets, evaluate them and then develop selected programmes through dedicated subsidiaries. These include Inaphaea BioLabs, which runs a …
Verici Dx develops clinical diagnostic tests for kidney transplant patients. Its tests use artificial intelligence-assisted analysis of RNA signatures to assess immune response, injury, rejection and the risk of graft failure. Its commercial product is Tutivia, while its pipeline includes a pre-transplant risk assessment …
4basebio (LSE:4BB) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
The FTSE 100 backdrop reflects mixed UK sentiment as economic resilience meets global market volatility.
Avacta Group (LSE:AVCT) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
Crism Therapeutics (LSE:CRTX) is included in this fresh batch of UK corporate-news coverage for 15 October 2026.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…